Immunic, Inc. Investing Cash Flow
Immunic, Inc. (IMUX) reported Investing Cash Flow of -$251.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-11
- Immunic, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$249.00K.
- Immunic, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$2.00K.
- Immunic, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$11.00K.
- Immunic, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$67.00K.
- Immunic, Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$161.00K.
- Immunic, Inc. net cash provided by (used in) investing activities for fiscal 2024 was -$264.00K, a 102.79% decline from fiscal 2023.
- Immunic, Inc. net cash provided by (used in) investing activities for fiscal 2023 was $9.46M.
- Immunic, Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$9.74M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 3 month as first filed | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$249.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$251.00K 10-Q · filed 2026-08-11 | -$262.00K derived: sum of 3 quarters · filed 2026-08-11 | -$329.00K derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2026-03-31 | -$2.00K 10-Q · filed 2026-05-13 | -$13.00K derived: sum of 2 quarters · filed 2026-05-13 | -$80.00K derived: sum of 3 quarters · filed 2026-05-13 | -$116.00K derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-12-31 | -$11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$78.00K derived: sum of 2 quarters · filed 2026-02-26 | -$114.00K derived: sum of 3 quarters · filed 2026-08-11 | -$161.00K 10-K · filed 2026-02-26 | |||
| 2025-09-30 | -$67.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$103.00K derived: sum of 2 quarters · filed 2026-08-11 | -$150.00K 10-Q · filed 2025-11-13 | -$153.00K derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-06-30 | -$36.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$83.00K 10-Q · filed 2026-08-11 | -$86.00K derived: sum of 3 quarters · filed 2026-08-11 | -$136.00K derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-03-31 | -$47.00K 10-Q · filed 2026-05-13 | -$50.00K derived: sum of 2 quarters · filed 2026-05-13 | -$100.00K derived: sum of 3 quarters · filed 2026-05-13 | -$280.00K derived: sum of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$53.00K derived: sum of 2 quarters · filed 2026-02-26 | -$233.00K derived: sum of 3 quarters · filed 2026-02-26 | -$264.00K 10-K · filed 2026-02-26 | |||
| 2024-09-30 | -$50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$230.00K derived: sum of 2 quarters · filed 2025-11-13 | -$261.00K 10-Q · filed 2025-11-13 | -$426.00K derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-06-30 | -$180.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$211.00K 10-Q · filed 2025-08-07 | -$376.00K derived: sum of 3 quarters · filed 2025-08-07 | -$420.00K derived: sum of 4 quarters · filed 2025-08-07 | |||
| 2024-03-31 | -$31.00K 10-Q · filed 2025-05-15 | -$196.00K derived: sum of 2 quarters · filed 2025-05-15 | -$240.00K derived: sum of 3 quarters · filed 2025-05-15 | $4.10M derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | -$165.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$209.00K derived: sum of 2 quarters · filed 2025-03-31 | $4.13M derived: sum of 3 quarters · filed 2025-03-31 | $9.46M 10-K · filed 2025-03-31 | |||
| 2023-09-30 | -$44.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $4.29M derived: sum of 2 quarters · filed 2024-11-07 | $9.63M 10-Q · filed 2024-11-07 | -$1.00K derived: sum of 4 quarters · filed 2024-11-07 | |||
| 2023-06-30 | $4.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $9.67M 10-Q · filed 2024-08-08 | $43.00K derived: sum of 3 quarters · filed 2024-08-08 | -$30.00K derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | $5.33M 10-Q · filed 2024-05-08 | -$4.29M derived: sum of 2 quarters · filed 2024-05-08 | -$4.37M derived: sum of 3 quarters · filed 2024-05-08 | -$4.39M derived: sum of 4 quarters · filed 2024-05-08 | |||
| 2022-12-31 | -$9.63M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$9.70M derived: sum of 2 quarters · filed 2024-02-22 | -$9.73M derived: sum of 3 quarters · filed 2024-02-22 | -$9.74M 10-K · filed 2024-02-22 | |||
| 2022-09-30 | -$73.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$101.00K derived: sum of 2 quarters · filed 2023-11-14 | -$113.00K 10-Q · filed 2023-11-14 | -$132.00K derived: sum of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | -$28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$40.00K 10-Q · filed 2023-08-03 | -$59.00K derived: sum of 3 quarters · filed 2023-08-03 | -$79.00K derived: sum of 4 quarters · filed 2023-08-03 | |||
| 2022-03-31 | -$12.00K 10-Q · filed 2023-05-11 | -$31.00K derived: sum of 2 quarters · filed 2023-05-11 | -$51.00K derived: sum of 3 quarters · filed 2023-05-11 | -$69.00K derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | -$19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$39.00K derived: sum of 2 quarters · filed 2023-02-23 | -$57.00K derived: sum of 3 quarters · filed 2023-02-23 | -$67.00K 10-K · filed 2023-02-23 | |||
| 2021-09-30 | -$20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$38.00K derived: sum of 2 quarters · filed 2022-11-03 | -$48.00K 10-Q · filed 2022-11-03 | -$72.00K derived: sum of 4 quarters · filed 2022-11-03 | |||
| 2021-06-30 | -$18.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$28.00K 10-Q · filed 2022-08-04 | -$52.00K derived: sum of 3 quarters · filed 2022-08-04 | -$115.00K derived: sum of 4 quarters · filed 2022-08-04 | |||
| 2021-03-31 | -$10.00K 10-Q · filed 2022-05-10 | -$34.00K derived: sum of 2 quarters · filed 2022-05-10 | -$97.00K derived: sum of 3 quarters · filed 2022-05-10 | -$152.00K derived: sum of 4 quarters · filed 2022-05-10 | |||
| 2020-12-31 | -$24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$87.00K derived: sum of 2 quarters · filed 2022-02-24 | -$142.00K derived: sum of 3 quarters · filed 2022-02-24 | -$146.00K 10-K · filed 2022-02-24 | |||
| 2020-09-30 | -$63.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$118.00K derived: sum of 2 quarters · filed 2021-11-04 | -$122.00K 10-Q · filed 2021-11-04 | -$147.00K derived: sum of 4 quarters · filed 2021-11-04 | |||
| 2020-06-30 | -$55.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | -$59.00K 10-Q · filed 2021-08-06 | -$84.00K derived: sum of 3 quarters · filed 2021-08-06 | $1.15M derived: sum of 4 quarters · filed 2021-08-06 | |||
| 2020-03-31 | -$4.00K 10-Q · filed 2021-05-06 | -$29.00K derived: sum of 2 quarters · filed 2021-05-06 | $1.21M derived: sum of 3 quarters · filed 2021-05-06 | $10.54M derived: sum of 4 quarters · filed 2021-05-06 | |||
| 2019-12-31 | -$25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $1.21M derived: sum of 2 quarters · filed 2021-02-26 | $10.54M derived: sum of 3 quarters · filed 2021-02-26 | $10.54M 10-K · filed 2021-02-26 | |||
| 2019-09-30 | $1.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $10.57M derived: sum of 2 quarters · filed 2020-11-06 | $10.56M 10-Q · filed 2020-11-06 | $10.54M derived: sum of 4 quarters · filed 2020-11-06 | |||
| 2019-06-30 | $9.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-03 | $9.32M 10-Q · filed 2020-08-03 | $9.30M derived: sum of 3 quarters · filed 2020-08-03 | ||||
| 2019-03-31 | -$7.00K 10-Q · filed 2020-05-08 | $10.00K 10-Q · filed 2019-04-10 | -$27.00K derived: sum of 2 quarters · filed 2020-05-08 | ||||
| 2018-12-31 | -$20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$32.00K 10-K · filed 2020-03-16 | -$415.00K 10-K · filed 2019-03-04 | ||||
| 2018-09-30 | -$12.00K 10-Q · filed 2019-11-07 | -$595.00K 10-Q · filed 2018-11-08 | |||||
| 2018-03-31 | -$150.00K 10-Q · filed 2019-04-10 | -$261.00K derived: sum of 2 quarters · filed 2019-04-10 | |||||
| 2017-12-31 | -$111.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-04 | -$678.00K 10-K · filed 2019-03-04 | |||||
| 2017-09-30 | -$567.00K 10-Q · filed 2018-11-08 | ||||||
| 2016-12-31 | -$21.00K 10-K · filed 2019-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B |